Dr. Gabriel Fitzpatrick:

Obviously, I have no available scientific paper on these vaccines because they have not been subject to large trials. One cannot make a judgment on whether to implement a vaccine programme on the basis of one or two people receiving a vaccine. A large number need to receive a vaccine and the results need to be compared with the results for those who have not received it. We do know that some physicians who have been infected have received the trial monoclonal antibody treatment and seem to have had a good response to it. However, we cannot make an inference that it will work for the general population because the numbers are too small.